A longitudinal record study of renal function in patients treated with lithium

Area of Science:

• Nephrology
• Psychiatry
• Pharmacology

Background:

• Lithium is a common mood stabilizer for bipolar disorder.
• Long-term lithium use raises concerns about potential kidney damage.
• Monitoring renal function is crucial for patients on lithium therapy.

Purpose of the Study:

• To investigate the association between long-term lithium therapy and renal function deterioration.
• To determine if lithium treatment duration impacts blood urea nitrogen (BUN), creatinine levels, or proteinuria.

Main Methods:

• Retrospective review of hospital charts for 62 patients on long-term lithium therapy.
• Analysis of changes in BUN, creatinine, and presence of proteinuria over time.
• Comparison of renal function parameters between baseline (index) and follow-up.

Main Results:

• No significant association was found between lithium treatment duration (up to four years) and changes in BUN or creatinine.
• No significant association was observed between lithium treatment duration and the development of proteinuria.
• Older age was associated with higher follow-up BUN and creatinine, independent of lithium treatment duration.

Conclusions:

• Long-term lithium therapy, up to four years, does not appear to be associated with significant renal function deterioration.
• Renal function monitoring in lithium-treated patients should consider age as a factor.
• Further research may be needed to assess very long-term effects or effects in specific patient populations.